52 Results for "

WRN

" in MedChemExpress (MCE) Product Catalog:
Products (52)

52 Results for "WRN" in MCE Product Catalog:

Cat. No.: HY-161386
CAS No.: 444780-45-4
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 7 (Compound h6) is a WRN inhibitor. WRN inhibitor 7 effectively inhibits WRN's helicase and ATPase activity (IC50: 9.8 μM and 15.8 μM respectively). WRN inhibitor 7 can be used for research of microsatellite instable (MSI) cancers .
loading...
    loading...
Cat. No.: HY-169423
CAS No.: 3064599-40-9
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 17 (Compound 250) is an orally active Werner Syndrome ATP dependent helicase enzyme (WRN) inhibitor, in particular inhibit WRN helicase domain activity. WRN inhibitor 17 is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-168592
CAS No.: 3044040-29-8
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 12 (compound 5) is an inhibitor of WRN helicase .
loading...
    loading...
Cat. No.: HY-178474
CAS No.: 3095277-20-3
Research Areas:  

Cancer

WRN inhibitor 20 (Compound 14c) is a WRN degradation agent. WRN inhibitor 20 exhibits strong degradation activity in various cells, such as HCT-116 (DC50 = 1.7 µM), SW-48 (DC50 = 3.0 µM), and SW-480 (DC50 = 5.9 µM) cells. WRN inhibitor 20 exhibits potent anti proliferative, pro apoptotic, migration inhibiting, and DNA damage inducing effects in MSI-H cells. WRN inhibitor 20 can be used for research on cancer .
loading...
    loading...
Cat. No.: HY-174217
CAS No.: 3058652-58-4
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-19 (Compound (S)-27) is a covalent WRN helicase inhibitor, with pIC50 (0 h/4 h) = 5.4/7.5 in the DNA-unwinding 5 endpoint assays. WRN-IN-19 shows synthetic lethality in MSI-H (high microsatellite instability) cancer cells .
loading...
    loading...
Cat. No.: HY-153973
CAS No.: 2923009-56-5
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 2 (example 118) is a WRN (Werner Syndrome ATP dependent helicase enzyme) inhibitor, with pIC50 ≥ 7.0 .
loading...
    loading...
Cat. No.: HY-168934
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

KWR137 is an orally active Werner protein (WRN) inhibitor with a human IC50 of 8 nM. KWR137 inhibits the ATPase activity required for WRN helicase function, induces WRN protein degradation, suppresses cancer cell proliferation, and slows tumor growth without causing weight loss or off-target effects. KWR137 can be used for the research of colorectal cancer .
loading...
    loading...
Cat. No.: HY-176727
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 19 (Compound 40) is a WRN helicase inhibitor (IC50: 3.7 nM). WRN inhibitor 19 exhibits selective antiproliferative activity in WRN-dependent cancer cells. WRN inhibitor 19 inhibits WRN helicase function by competitively binding to the ATP site and induces DNA damage and cell cycle arrest. WRN inhibitor 19 can be used in the study of WRN-dependent cancers .
loading...
    loading...
Cat. No.: HY-157954
Research Areas:  

Cancer

WRN inhibitor 6 (compound 3ci) is a potent WRN inhibitor. WRN inhibitor 6 induces apoptosis. WRN inhibitor 6 increases the expression of p-p53, P-Chk2, γH2AX expression .
loading...
    loading...
Cat. No.: HY-163941
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

GSK_WRN2 is a potent and selective covalent WRN helicase inhibitor that suppresses replication stress caused by DNA (TA)n dinucleotide repeat expansions. GSK_WRN2 can be used to study microsatellite instability (MSI) cancers .
loading...
    loading...
Cat. No.: HY-163797
CAS No.: 3049092-06-7
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 10 (Compound P24) is an inhibitor for the Werner helicase WRN with an IC50 of 1.1 nM. WRN inhibitor 10 inhibits the proliferation of cancer cell SW48 with IC50 of 39 nM. WRN inhibitor 10 exhibits good liver microsomal stability and film permeability. WRN inhibitor 10 exhibits good pharmacokinetic characteristics in CD-1 mice .
loading...
    loading...
Cat. No.: HY-164852
CAS No.: 2923009-51-0
Target:  

DNA/RNA Synthesis

Research Areas:  

Others

WRN inhibitor 13 is a WRN helicase inhibitor with a pIC50 of 6-7 .
loading...
    loading...
Cat. No.: HY-176912
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN-IN-22 (compound A01) is a potent Werner syndrome RecQ helicase (WRN) inhibitor (IC50 < 100 nM). WRN-IN-22 can be used for microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer research, such as colorectal, gastric, prostate and endometrial cancer .
loading...
    loading...
Cat. No.: HY-168583
CAS No.: 3058317-61-3
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 11 (Example 17) is an orally active inhibitor of WRN helicase, with the IC50 of 63 nM .
loading...
    loading...
Cat. No.: HY-169424
CAS No.: 3064599-42-1
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 18 (compound 306) is an orally available inhibitor of WRN with in vivo anticancer activity .
loading...
    loading...
Cat. No.: HY-169928
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 14 (compound S35) is an orally active WRN inhibitor with anticancer activity. WRN inhibitor 14 results in tumor growth inhibition in the SW48 xenograft model in BALB/c nude mice .
loading...
    loading...
Cat. No.: HY-169414
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

WRN inhibitor 15 (Compound 9) is a WRN inhibitor with anti-tumor activity that can be used in prostate cancer research, the IC50 values are 37.9, 40.2 and 46.6 μM in PC3, LNCaP, and HeLa .
loading...
    loading...
Cat. No.: HY-RS15847
Research Areas:  

Others

WRN Human Pre-designed siRNA Set A contains three designed siRNAs for WRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS22970
Research Areas:  

Others

Wrn Rat Pre-designed siRNA Set A contains three designed siRNAs for Wrn gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-168933
CAS No.: 3057980-16-9
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

KWR095 is an orally active WRN inhibitor with an IC50 of 0.032 μM for WRN ATPase. KWR095 can impede the duplex unwinding activity of WRN and inhibit the proliferation of tumor cells. KWR095 has anti-tumor activity .
loading...
    loading...